Significance of PELP1 signaling in liver cancer progression

被引:0
|
作者
Pratap, Uday
Nassar, Khaled Mohamed
Yang, Xue
Baker, Adriana
Gopalam, Rahul
Arnold, William C.
Adeniran, Timilehin
Hernandez Fernandez, Marian Helena
Sareddy, Gangadhara R.
Viswanadhapalli, Suryavathi
Sun, Luzhe
Vadlamudi, Ratna K.
机构
关键词
D O I
10.1158/1538-7445.AM2024-3172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3172
引用
收藏
页数:2
相关论文
共 50 条
  • [1] PELP1: A review of PELP1 interactions, signaling, and biology
    Girard, Brian J.
    Daniel, Andrea R.
    Lange, Carol A.
    Ostrander, Julie H.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 382 (01) : 642 - 651
  • [2] PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
    Sareddy, Gangadhara R.
    Pratap, Uday P.
    Viswanadhapalli, Suryavathi
    Venkata, Prabhakar Pitta
    Nair, Binoj C.
    Krishnan, Samaya Rajeshwari
    Zheng, Siyuan
    Gilbert, Andrea R.
    Brenner, Andrew J.
    Brann, Darrell W.
    Vadlamudi, Ratna K.
    NEURO-ONCOLOGY ADVANCES, 2019, 1 (01)
  • [3] PELP1 is a novel mediator of medulloblastoma progression
    Luo, Yiliao
    Sareddy, Gangadhara Reddy
    Pratap, Uday P.
    Li, Mengxing
    Liu, Junhao
    Pitta-Venkata, Prabhakar
    Viswanadhapalli, Suryavathi
    Li, Xiaonan
    Rao, Manjeet
    Tekmal, Rajeshwar Rao
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2019, 79 (13)
  • [4] PELP1: A novel therapeutic target for ovarian cancer progression and metastasis
    Chakravarty, Dimple
    Challa, Rambabu
    Dandamudi, Rajasekhar
    Vivas-Mejia, Pablo
    Lopez-Berestein, Gabriel
    Tekmal, Rajeshwar Rao
    Sood, Anil K.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2010, 70
  • [5] Significance of PELP1 in ER-Negative Breast Cancer Metastasis
    Roy, Sudipa
    Chakravarty, Dimple
    Cortez, Valerie
    De Mukhopadhyay, Keya
    Bandyopadhyay, Abhik
    Ahn, Jung-Mo
    Raj, Ganesh V.
    Tekmal, Rajeshwar R.
    Sun, LuZhe
    Vadlamudi, Ratna K.
    MOLECULAR CANCER RESEARCH, 2012, 10 (01) : 25 - 33
  • [6] PELP1 is a novel reader of chromatin modifications: Implications in cancer progression
    Vadlamudi, Ratna K.
    Mann, Monica
    Cortez, Valerie A.
    CANCER RESEARCH, 2011, 71
  • [7] PELP1: A novel therapeutic target for ovarian cancer progression and metastasis
    Chakravarty, Dimple
    Challa, Rambabu
    Dandamudi, Rajasekhar
    Vivas-Mejia, Pablo
    Lopez-Berestein, Gabriel
    Tekmal, Rajeshwar Rao
    Sood, Anil K.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2010, 70
  • [8] The role of PELP1/MNAR in progression and metastasis of breast cancer.
    Rajhans, R.
    Nair, S. S.
    De La Pena Jr., M. O.
    Alan, H.
    Kumar, R.
    Rajeshwar, T. R.
    Vadlamudi, R. K.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S13 - S13
  • [9] Emerging significance of ER-coregulator PELP1/MNAR in cancer
    Nair, S.
    Vadlamudi, R. K.
    HISTOLOGY AND HISTOPATHOLOGY, 2007, 22 (01) : 91 - 96
  • [10] The prognostic Significance of the Estrogen Receptor Regulator PELP1 in Ovarian Cancer
    Aust, S.
    Pils, S.
    Polterauer, S.
    Natter, C.
    Castillo-Tong, D. Cacsire
    Zeillinger, R.
    Hefler, L.
    Reinthaller, A.
    Grimm, C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)